Product Research Department, Fuji-Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd., Gotemba, Japan.
Cytokine. 2012 Jun;58(3):424-30. doi: 10.1016/j.cyto.2012.02.010. Epub 2012 Mar 19.
Patients with chronic inflammatory disorders such as rheumatoid arthritis (RA) have a high risk of developing cardiovascular disease. We evaluated the effects of TNF-α and IL-6 on foam cell formation, a pivotal process in atherogenesis. Accumulation of intracellular oxidized LDL (oxLDL) was induced when THP-1/macrophages were stimulated with TNF-α or IL-6. TNF-α induced the expressions of scavenger receptors SR-A and LOX-1, and IL-6 induced SR-A expression. Inhibition of the NF-κB signaling markedly decreased TNF-α-induced foam cell formation and SR-A expression. Serum from RA patients, but not healthy subjects, induced foam cell formation, which was partially reversed by either IL-6 or TNF-α blockade in conjunction with inhibiting the induction of scavenger receptors. The present study clearly showed that in patients with chronic inflammation mediated by TNF-α and IL-6, these cytokines are directly implicated in atherosclerotic plaque formation.
患有慢性炎症性疾病(如类风湿关节炎)的患者发生心血管疾病的风险很高。我们评估了 TNF-α 和 IL-6 对泡沫细胞形成的影响,泡沫细胞形成是动脉粥样硬化形成的关键过程。当 THP-1/巨噬细胞受到 TNF-α 或 IL-6 刺激时,会诱导细胞内氧化 LDL(oxLDL)的积累。TNF-α 诱导了清道夫受体 SR-A 和 LOX-1 的表达,而 IL-6 诱导了 SR-A 的表达。NF-κB 信号通路的抑制显著降低了 TNF-α 诱导的泡沫细胞形成和 SR-A 的表达。来自 RA 患者的血清而不是健康受试者的血清诱导了泡沫细胞形成,这种形成部分可以通过 IL-6 或 TNF-α 阻断以及抑制清道夫受体的诱导来逆转。本研究清楚地表明,在由 TNF-α 和 IL-6 介导的慢性炎症患者中,这些细胞因子直接参与动脉粥样硬化斑块的形成。